Elan

Turning Elan around
Irish Independent, Ireland
Sat, 04/28/12 - 01:12 pm
Elan
Valeant Headed Into High Growth Phase
Seeking Alpha
Wed, 04/11/12 - 09:33 am
Valeant Pharmaceuticals
Elan
GSK
Merck
Pfizer
9 Undervalued Healthcare Stocks With Strong Hedge Fund Buying
Seeking Alpha
Sun, 04/1/12 - 11:43 am
Akorn
Depomed
Cigna
Elan
PDL Biopharma
Questcor Pharmaceuticals
USANA Health Sciences
Transcend Medical
Sun Healthcare Group
Elan's Alzheimer's-Fueled Run Means Investors Are Forgetting the Past
TheStreet.com
Mon, 03/19/12 - 10:20 am
Elan
Alzheimer's disease
bapineuzumab
Elan to bank $381 million from sale of Alkermes stock
Pharma Times, UK
Wed, 03/14/12 - 09:45 am
Alkermes
Elan
Elan CEO to stay on past scheduled exit at board request pending release of critical drug data
Yahoo/AP
Thu, 03/1/12 - 12:30 pm
Elan
Pharma CEOs
Kelly Martin
Alzheimer's disease
Tuesday's Bio Pharma Watch List
Seeking Alpha
Tue, 02/28/12 - 10:50 am
Jazz Pharmaceuticals
Questcor
Amarin
Elan
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
TheStreet.com
Tue, 02/21/12 - 08:59 am
Elan
Alzheimer's disease
bapineuzumab
monoclonal antibodies
Biogen Idec: The Patriots of Biotechs
PharmExec
Thu, 02/2/12 - 11:06 am
Biogen Idec
Tysabri
Elan
biotech
BG-12
MS
multiple sclerosis
Biogen, Elan Win U.S. FDA Approval of Tysabri Label Change to Target Use
Bloomberg
Sat, 01/21/12 - 01:04 pm
Biogen Idec
Elan
Tysabri
multiple sclerosis
The War Against Alzheimer's Requires Thinking Small
Investopedia
Tue, 01/3/12 - 10:14 am
Alzheimer's disease
AstraZeneca
Astex
Elan
Intellect Neurosciences
Pfizer
Elan Looks To Gain on Rumors of Possible Takeover Bid From Johnson & Johnson
BioMedReports
Sat, 12/31/11 - 12:56 pm
Elan
JNJ
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Elan Posts Profit on Tysabri Gains, Sale of Technology Unit
Bloomberg
Thu, 10/27/11 - 11:40 am
Elan
earnings
Tysabri
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Bloomberg
Thu, 10/20/11 - 09:17 am
Biogen Idec
FDA
Elan
Tysabri
MS
multiple sclerosis
Elan ‘Just Starting’ May Reward Investors After 10-Year Drop
Bloomberg
Wed, 10/19/11 - 09:37 am
Elan
investors
Jefferies analyst upgrades Alkermes to 'buy' after completion of acquisition, move to Ireland
Yahoo/AP
Mon, 09/26/11 - 11:03 am
Alkermes
M&A
drug delivery
Elan
Roche Signs First Alzheimer's Deal Of 2011 As Crucial Progress Awaited
Seeking Alpha
Wed, 09/7/11 - 09:34 am
Roche
Alzheimer's disease
Ranbaxy
Elan
JNJ
Eli Lilly
Pfizer

Pages